Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo

Nature Medicine

Volumn 10, Issue 2, 2004, Pages 168-174

  Inoue, Hiroshi ^a   Ogawa, Wataru ^a   Ozaki, Michitaka ^b,c   Haga, Sanae ^b   Matsumoto, Michihiro ^a   Furukawa, Kensuke ^a   Hashimoto, Naoko ^a   Kido, Yoshiaki ^a   Mori, Toshiyuki ^a   Sakaue, Hiroshi ^a   Teshigawara, Kiyoshi ^a   Jin, Shiyu ^a   Iguchi, Haruhisa ^d   Hiramatsu, Ryuji ^d   LeRoith, Derek ^e   Takeda, Kiyoshi ^f   Akira, Shizuo ^f   Kasuga, Masato ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

^d DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

^e NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^f OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CARBOHYDRATE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; STAT3 PROTEIN; CELL SURFACE RECEPTOR; DNA BINDING PROTEIN; INSULIN; LEPTIN RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1; PEROXISOME-PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA COACTIVATOR-1; STAT3 PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; CYCLIC AMP RESPONSIVE ELEMENT; DIABETES MELLITUS; DISEASE ASSOCIATION; GENE; GENE CONTROL; GENE EXPRESSION; GENE TRANSFER; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIVER; LIVER CELL CULTURE; METABOLIC DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; REGULATORY MECHANISM; VIRUS INFECTION; ANIMAL; CELL CULTURE; CYTOLOGY; FAT INTAKE; GENETICS; LIVER CELL; MALE; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY;

ADENOVIRIDAE; ANIMALIA;

ADENOVIRIDAE; ANIMALS; BLOOD GLUCOSE; CARBOHYDRATE METABOLISM; CELLS, CULTURED; DIABETES MELLITUS; DIETARY FATS; DNA-BINDING PROTEINS; GENE TRANSFER TECHNIQUES; GLUCONEOGENESIS; HEPATOCYTES; INSULIN; LIVER; MALE; MICE; MICE, KNOCKOUT; RECEPTORS, CELL SURFACE; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 11144357516     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm980     Document Type: Article

References (37)

1. Taylor, S. I. Deconstructing type 2 diabetes. Cell 97, 9-12 (1999).
2. Radziuk, J. & Pye, S. Hepatic glucose uptake, gluconeogenesis and the regulation of glycogen synthesis. Diabet. Metab. Res. Rev. 17, 250-272 (2001).
3. Shimomura, I. et al. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol. Cell 6, 77-86 (2000).
4. Michael, M.D. et al. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol. Cell 6, 87-97 (2000).
5. Trinh, K.Y., O'Doherty, R.M., Anderson, P., Lange, A.J. & Newgard, C.B. Perturbation of fuel homeostasis caused by overexpression of the glucose-6-phosphatase catalytic subunit in liver of normal rats. J. Biol. Chem. 273, 31615-31620 (1998).
6. Valera, A., Pujol, A., Pelegrin, M. & Bosch, F. Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. USA 91, 9151-9154 (1994).
7. Rosella, G. et al. Impaired glucose tolerance and increased weight gain in transgenic rats overexpressing a non-insulin-responsive phosphoenolpyruvate carboxykinase gene. Mol. Endocrinol. 9, 1396-1404 (1995).
8. Sun, Y. et al. Phosphoenolpyruvate carboxykinase overexpression selectively attenuates insulin signaling and hepatic insulin sensitivity in transgenic mice. J. Biol. Chem. 277, 23301-23307 (2002).
9. O'Brien, R.M. & Granner, D.K. Regulation of gene expression by insulin. Physiol. Rev. 76, 1109-1161 (1996).
10. Christ, B., Yazici, E. & Nath, A. Phosphatidylinositol 3-kinase and protein kinase C contribute to the inhibition by interleukin 6 of phosphoenolpyruvate carboxykinase gene expression in cultured rat hepatocytes. Hepatology 31, 461-468 (2000).
11. Metzger, S. et al. Interleukin-6 secretion in mice is associated with reduced glucose-6-phosphatase and liver glycogen levels. Am. J. Physiol. 273, E262-E267 (1997).
12. Akira, S., Taga, T. & Kishimoto, T. Interleukin-6 in biology and medicine. Adv. Immunol. 54, 1-78 (1993).
13. Febbraio, M.A. & Pedersen, B.K. Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J. 16, 1335-1347 (2002).
14. Vgontzas, A.N., Papanicolaou, D.A., Bixler, E.O., Kales, A., Tyson, K., & Chrousos, G.P. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J. Clin. Endocrinol. Metab. 82, 1313-1316 (1997).
15. Levy, D.E. & Lee, C.-K. What does Stat3 do? J. Clin. Invest, 109, 1143-1148 (2002).
16. Takeda, K. et al. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. USA 94, 3801-3804 (1997).
17. Yaker, S. et al. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc. Natl. Acad. Sci. USA 96, 7324-7329 (1999).
18. Takeda, K. etal. Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. J. Immunol. 161, 4652-4560 (1998).
19. Yoon, J.C. et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413, 131-138 (2001).
20. Horton, J.D., Goldstein, J.L. & Brown, M.S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109, 1125-1131 (2002).
21. Miyake, K. et al. Hyperinsulinemia, glucose intolerance, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liver. J. Clin. Invest. 110, 1483-1491 (2002).
22. Minami, M. et al. STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line. Proc. Natl. Acad. Sci. USA 93, 3963-3966 (1996).
23. Nakae, J., Kitamura, T., Silver, D.L., & Accili, D. The forkhead transcription factor Foxol (Fkhr) confers insulin sensitivity. onto glucose-6-phosphatase expression. J. Clin. Invest. 108, 1359-67 (2001).
24. Puigserver, P et al. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1a interaction. Nature 423, 550-555, (2003).
25. Scott, D.K., O'Doherty, R.M., Stafford, J.M., Newgard, C.B., & Granner, D.K. Therepression of hormone-activated PEPCK gene expression by glucose is insulin-independent but requires glucose metabolism. J. Biol. Chem. 273, 24145-24151 (1998).
26. Kotani, K et al. Dominant negative forms of Akt (protein kinase B) and atypical protein kinase Cλ do not prevent insulin inhibition of phosphoenolpyruvate carboxykinase gene transcription. J. Biol. Chem. 274, 21305-21312 (1998).
27. Herzig, S et al. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 413, 179-183 (2001).
28. Lee, G.-H. et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 379,632-635 (1996).
29. Bromberg, J.F. et al. Stat3 as an oncogene. Cell 98, 295-303 (1999).
30. Strassmann, G., Fong, M., Windsor, S. & Neta, R. The role of interleukin-6 in lipopolysaccharide-induced weight loss, hypoglycemia and fibrinogen production in vivo. Cytokine 5, 285-290 (1993).
31. Wallenius, V. et al. Interleukin-6-deficient mice develop mature-onset obesity. Nature Med. 8, 75-79 (2002).
32. Bluher, M et al. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev. Cell. 3, 25-38 (2002).
33. Kitamura, T. et al. Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serine-threonine kinase Akt. Mol. Cell. Biol. 19, 6286-6296 (1999).
34. Ozaki, M. et al. Inhibition of the Rac1 GTPase protects against nonlethal ischemia/reperfusion-induced necrosis and apoptosis in vivo. FASEB J. 14, 418-429 (2000).
35. Ren, J.M., Marshal,l B.A., Mueckler, M.M., McCaleb, M., Amatruda, J.M., & Shulman, G.I. Overexpression of Glut4 protein in muscle increases basal and insulin-stimulated whole body glucose disposal in conscious mice. J. Clin. Invest. 95, 429-432 (1995).
36. Matsumoto, M. et al. PKCλ in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall insulin sensitivity. J. Clin. Invest. 112, 935-944 (2003).
37. Matsumoto, M. et al. Role of the insulin receptor substrate 1 and phosphatidylinositol 3-kinase signaling pathway in insulin-induced expression of sterol regulatory element binding protein 1c and glucokinase genes in rat hepatocytes. Diabetes 51, 1672-1680 (2002).